Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target

E-ISSN： 1875-533x|13|17|1971-1978

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.17, 2006-07, pp. : 1971-1978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes

Current Drug Targets, Vol. 8, Iss. 10, 2007-10 ,pp. : 1138-1143

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 937-943

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating Soluble Receptor for Advanced Glycation End Products is Inversely Correlated to Oxidized Low-density Lipoproteins in Asymptomatic Subjects

By Kotani K Caccavello R Taniguchi N Gugliucci A

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1878-1883

Field House Publishing

Access to resources Recommend Favorite

Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis

Journal of Digestive Diseases, Vol. 17, Iss. 7, 2016-07 ,pp. : 475-482

John Wiley & Sons Inc

Access to resources Recommend Favorite